Damora Therapeutics, Inc. (DMRA) vs Innovage Holding Corp. (INNV)
A side-by-side comparison of Damora Therapeutics, Inc. and Innovage Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$19.02HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
INNV
Innovage Holding Corp.
$8.98HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — DMRA vs INNV
growth of $100 · dividends reinvested · last 6yDMRA -92.0% (-34.4%/yr)INNV -62.8% (-15.2%/yr)INNV compounded faster over this window
DMRA INNV
DMRA vs INNV: by the numbers
- •INNV is the larger company ($1.22B vs $1.17B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -0.26% net margin).
Metrics side by side
Valuation
| Metric | DMRA | INNV |
|---|---|---|
| Forward P/E | N/A | 20.38 |
| P/S ratio | N/A | 1.23 |
| P/B ratio | 3.03 | 5.17 |
| EV / EBITDA | N/A | 14.31 |
| FCF yield | N/A | 4.14% |
Profitability
| Metric | DMRA | INNV |
|---|---|---|
| Gross margin | 0.00% | 21.39% |
| Operating margin | 0.00% | 6.39% |
| Net margin | 0.00% | -0.26% |
| ROE | -50.93% | -1.08% |
| ROIC | -52.44% | 9.48% |
Growth (annualized)
| Metric | DMRA | INNV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.19% |
| Total return CAGR (5Y) | -25.05% | 5.55% |
Frequently asked
- How have DMRA and INNV total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and INNV delivered 5.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Damora Therapeutics ROEInnovage ROEDamora Therapeutics operating marginInnovage operating marginDamora Therapeutics revenue growthInnovage revenue growthDamora Therapeutics free cash flowInnovage free cash flow
Damora Therapeutics & Innovage appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.